/

Empresas

ST

No verificado

STORM Therapeutics

Sobre qué escribimos

BiologíaFarmacéuticaFinanzasSanidadTelecomunicaciones

3 Comunicados de prensa

Ver todos los comunicados de prensa

27/05/2025

Farmacéutica

Tecnología de la información

Telecomunicaciones

Sanidad

Biología

STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer

Fuente

STORM Therapeutics

Editor

1.00

0

11/11/2024

Farmacéutica

Sanidad

Finanzas

Biología

STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024

Fuente

STORM Therapeutics

Editor

1.00

0

17/06/2024

Farmacéutica

Sanidad

Sociedad

Biología

Tony Kouzarides, Founder of STORM Therapeutics, Awarded British Knighthood for Services to Healthcare Innovation and Delivery

Fuente

STORM Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0